Treasure Valley Metabolic Medicine

Treasure Valley Metabolic Medicine operates in Eagle, Idaho, under the clinical direction of Katy Connley, MSN, APRN, FNP-C, BC-ADM. Connley holds board certification in Advanced Diabetes Management (BC-ADM), positioning the clinic to address complex metabolic conditions including type 2 diabetes, prediabetes, metabolic syndrome, thyroid disorders, and adrenal dysfunction. The practice serves patients throughout the Treasure Valley region seeking medical intervention for weight-related metabolic complications and endocrine imbalances that resist conventional primary care approaches.

The clinic prescribes three GLP-1 receptor agonist peptides for metabolic management: Liraglutide, Semaglutide, and Tirzepatide. These medications work by mimicking incretin hormones to regulate blood glucose, slow gastric emptying, and reduce appetite through central nervous system pathways. Liraglutide is administered as a daily subcutaneous injection and carries FDA approval for both type 2 diabetes and chronic weight management in adults with obesity or overweight status plus weight-related comorbidities. Semaglutide, available in weekly injection form, demonstrates greater weight reduction outcomes in clinical trials and is prescribed for similar indications. Tirzepatide represents a dual GIP/GLP-1 receptor agonist with enhanced efficacy data for both glycemic control and weight loss, approved for type 2 diabetes management. Connley evaluates patient candidacy based on BMI, hemoglobin A1c levels, cardiovascular risk factors, and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

As a board-certified Family Nurse Practitioner with specialized diabetes management credentials, Connley conducts comprehensive metabolic assessments that include fasting glucose and insulin levels, lipid panels, thyroid function tests (TSH, free T3, free T4), and adrenal hormone evaluation when clinically indicated. Her approach integrates peptide therapy with nutritional counseling, lifestyle modification protocols, and management of comorbid conditions such as hypertension, dyslipidemia, and polycystic ovary syndrome. Patients with thyroid disorders receive evaluation for Hashimoto's thyroiditis, hypothyroidism, and subclinical thyroid dysfunction, with treatment adjustments based on symptom response and laboratory trends. Adrenal disorder assessment addresses cortisol dysregulation, though the clinic does not claim to diagnose rare conditions like Addison's disease or Cushing's syndrome without appropriate endocrinology collaboration.

Treasure Valley Metabolic Medicine requires in-person consultations at the Eagle, Idaho location, allowing for direct physical examination, vital sign monitoring, and injection technique training. Initial appointments typically involve detailed medical history review, medication reconciliation, and establishment of individualized treatment goals with measurable endpoints such as target A1c reduction or percentage body weight loss. Follow-up visits occur at intervals determined by medication titration schedules and patient response, with most GLP-1 therapy patients seen every 4-8 weeks during dose escalation phases. The clinic monitors for common adverse effects including nausea, gastrointestinal disturbances, and injection site reactions, adjusting protocols to optimize tolerance. Patients receive education on recognizing symptoms of hypoglycemia when peptides are combined with insulin or sulfonylureas, and guidance on managing medication during illness or surgical procedures.

With a 4.2-star rating across 41 Google reviews, the practice demonstrates patient satisfaction levels that reflect real-world clinical outcomes and service experiences. The Eagle location serves residents of Ada County and surrounding Treasure Valley communities including Boise, Meridian, and Nampa who seek specialized metabolic care beyond standard family medicine offerings. Connley's BC-ADM certification requires ongoing continuing education in diabetes technology, pharmacotherapy advances, and evidence-based metabolic disease management, ensuring patients access current treatment protocols. The clinic does not offer telehealth services, maintaining an in-person model that facilitates hands-on patient education, body composition assessment, and immediate clinical decision-making for patients with complex metabolic presentations requiring nuanced pharmaceutical management.